Chronic heart rate reduction with ivabradine and prevention of atherosclerosis progression assessed using intravascular ultrasound
Department of Medicine, Montreal Heart Institute, Montreal, Canada
* Jean-Claude Tardif, MD, Montreal Heart Institute, 5000 Belanger Street East, Montreal, Quebec, Canada, H1T 1C8.
Abstract
Experimental data have shown that reduction in atherosclerosis progression can be obtained through chronic heart rate reduction. Heart rate is significantly correlated with the severity and progression of atherosclerosis on coronary angiography in patients. Limitation of the progression of atherosclerosis may therefore become an important therapeutic target of the specific heart rate reducing agent ivabradine. The ability of intravascular ultrasound (IVUS) to assess plaque burden precisely makes it the ideal tool for a clinical trial of progression and regression of atherosclerosis. The present article provides an overview of the design and of some methodological features of a clinical trial to assess the effects of ivabradine on the progression of coronary atherosclerosis, as assessed by IVUS.
Key Words: Atherosclerosis Coronary artery disease Heart rate reduction Intravascular ultrasound Sinoatrial node
References
- Dyer AR, Persky V, Stamler J, et al. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol. 1980;112:736749
[Abstract/Free Full Text] - Kannel WB, Kannel C, Paffenbarger RS, Cupples LA. Heart rate and cardiovascular mortality: the Framingham study. Am Heart J. 1987;113:14891494[CrossRef][Web of Science][Medline]
- Gillum RF, Makuc DM, Feldman JJ. Pulse rate, coronary heart disease, and death: the NHANES I epidemiologic follow-up study. Am Heart J. 1991;121:172177[CrossRef][Web of Science][Medline]
- Kjekshus J. Importance of heart rate in determining beta-blocker efficacy in acute and long-term myocardial infarction intervention trials. Am J Cardiol. 1986;57:43F49F[CrossRef][Medline]
- Packer M, Coats AJS, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:16511658
[Abstract/Free Full Text] - Braunwald E. Expanding indications for beta-blockers in heart failure. N Engl J Med. 2001;344:17111712
[Free Full Text] - Persky A, Olsson G, Landou C, deFaire U, Theorell T, Hamstern A. Minimum heart rate and coronary atherosclerosis: independent relations to global severity and rate of progression of angiographic lesions in men with myocardial infarction at a young age. Am Heart J. 1992;123:606616
- Persky A, Hamstern A, Lindwall K, Theorell T. Heart rate correlates with severity of coronary atherosclerosis in young post-infarction patients. Am Heart J. 1988;116:13691373[CrossRef][Web of Science][Medline]
- Beere PA, Glagov S, Zarins CK. Retarding effect of lowered heart rate on coronary atherosclerosis. Science. 1984;226:180182
[Abstract/Free Full Text] - Kaplan JR, Manuck S, Adams MR, Weingand KW, Clarkson TB. Inhibition of coronary atherosclerosis by propranolol in behaviorally predisposed monkeys fed an atherogenic diet. Circulation. 1987;76:13641372
[Abstract/Free Full Text] - Strawn WB, Bondjers G, Kaplan JR, et al. Endothelial dysfunction in response to psychosocial stress in monkeys. Circ Res. 1991;68:12701279
[Abstract/Free Full Text] - Skantze HB, Kaplan J, Pettersson K, et al. Psychosocial stress causes endothelial injury in cynomolgus monkeys via beta1-adrenoceptor activation. Atherosclerosis. 1998;136:153161[CrossRef][Web of Science][Medline]
- Hedblad B, Wikstrand J, Janzon L, Wedel H, Berglund G. Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness. Main results from the ß-blocker cholesterol-lowering asymptomatic plaque study (BCAPS). Circulation. 2001;103:17211726
[Abstract/Free Full Text] - Thollon C, Cambarrat C, Vian J, Prost JF, Peglion JL, Vilaine JP. Electrophysiological effects of S16257 [GenBank] , a novel sino-atrial node modulator, on rabbit and guinea-pig cardiac preparations: comparison with UL-FS 49. Br J Pharmacol. 1994;112:3742[Web of Science][Medline]
- Tardif JC, Lee HS. Applications of intravascular ultrasound in cardiology. Reiber JHC, van der Wall EE. What's New in Cardiovascular Imaging?. Dordrecht: Kluwer Academic Publishers; 1998. p. 133148
- Porter TR, Sears T, Xie F, et al. Intravascular ultrasound study of angiographically mildly diseased coronary arteries. J Am Coll Cardiol. 1993;22:18581865[Abstract]
- Côté G, Tardif JC, Lespérance J, et al. Effects of probucol on vascular remodeling after coronary angioplasty. Circulation. 1999;99:3035
[Abstract/Free Full Text] - Nissen S. Coronary angiography and intravascular ultrasound. Am J Cardiol. 2001;87:15A20A (suppl)[CrossRef][Web of Science][Medline]
- Tardif JC, Pandian NG. Intravascular ultrasound imaging in peripheral arterial and coronary artery disease. Curr Opin Cardiol. 1994;9:627633[CrossRef][Web of Science][Medline]
- Tardif JC, Pandian NG. Intravascular and intracardiac ultrasound. Coron Artery Dis. 1995;6:3341
- Tardif JC. The future of intravascular ultrasound in the detection and management of coronary artery disease. Can J Cardiol. 2000;16(suppl D):12D15D
- Von Birgelen C, de Feyter PJ, de Very EA, et al. Simpson's rule for the volumetric ultrasound assessment of atherosclerotic coronary arteries: a study with ECG-gated three-dimensional intravascular ultrasound. Coron Artery Dis. 1997;8:363369[Web of Science][Medline]
- Liebson PR, Klein LW. Intravascular ultrasound in coronary atherosclerosis: a new approach to clinical assessment. Am Heart J. 1992;123:16431660[CrossRef][Web of Science][Medline]
- Tardif JC, Grégoire J, Schwartz L, et al. Effects of AGI-1067 and probucol after percutaneous coronary interventions. Circulation. 2003;107:552558
[Abstract/Free Full Text] - Matar FA, Mintz GS, Douek P, et al. Coronary artery lumen volume measurement using three-dimensional intravascular ultrasound: validation of a new technique. Cathet Cardiovasc Diagn. 1994;33:214220[Web of Science][Medline]
- Hausmann D, Erbel R, Alibelli-Chemarin MJ, et al. The safety of intracoronary ultrasound. A multi-center survey of 2207 examinations. Circulation. 1995;91:623630
[Abstract/Free Full Text] - Pinto FJ, StGoar F, Gao SZ, et al. Immediate and one-year safety of intracoronary ultrasonic imaging. Evaluation with serial quantitative angiography. Circulation. 1993;88:17091714
[Abstract/Free Full Text] - Mann JM, Davies MJ. Vulnerable plaque. Relation of characteristics to degree of stenosis in human coronary arteries. Circulation. 1996;94:928931
[Abstract/Free Full Text] - Sonka M, Zhang X. Assessment of plaque composition using intravascular ultrasound. Reiber JHC, van der Wall EE. What's New in Cardiovascular Imaging?. Dordrecht: Kluwer Academic Publishers; 1998. p. 183196
- Di Mario C, Gorge G, Peters R, et al. Clinical application and image interpretation in intracoronary ultrasound. Eur Heart J. 1998;19:207229
[Free Full Text] - Palmer ND, Northridge D, Lessells A, McDicken WN, Fox KAA. In vitro analysis of coronary atheromatous lesions by intravascular ultrasound. Reproducibility and histological correlation of lesion morphology. Eur Heart J. 1999;20:17011706
[Abstract/Free Full Text] - Hodgson JM, Reddy KG, Suneja R, Nair RN, Lesnefsky EJ, Sheehan HM. Intracoronary ultrasound imaging: correlation of plaque morphology with angiography, clinical syndrome, and procedural results in patients undergoing coronary angioplasty. J Am Coll Cardiol. 1993;21:3544[Abstract]
- Tardif JC, Bertrand OF, Mongrain R, et al. Reliability of mechanical and phased-array designs for serial intravascular ultrasound examinations. Int J Card Imaging. 2000;16:365375[CrossRef][Web of Science][Medline]
- Tardif JC, Lee HS, Harel F, et al. Deleterious effects of high-dosage vitamins on plaque composition: IVUS findings from the MultiVitamins and Probucol (MVP) trial. Circulation. 1999;100:182 (suppl)
- Tardif JC, Grégoire J, Lespérance J, et al. Design features of the Avasimibe and Progression of coronary Lesions assessed by intravascular UltraSound (A-PLUS) clinical trial. Am Heart J. 2002;144:589596[Web of Science][Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||